<code id='DCCCC6FCD4'></code><style id='DCCCC6FCD4'></style>
    • <acronym id='DCCCC6FCD4'></acronym>
      <center id='DCCCC6FCD4'><center id='DCCCC6FCD4'><tfoot id='DCCCC6FCD4'></tfoot></center><abbr id='DCCCC6FCD4'><dir id='DCCCC6FCD4'><tfoot id='DCCCC6FCD4'></tfoot><noframes id='DCCCC6FCD4'>

    • <optgroup id='DCCCC6FCD4'><strike id='DCCCC6FCD4'><sup id='DCCCC6FCD4'></sup></strike><code id='DCCCC6FCD4'></code></optgroup>
        1. <b id='DCCCC6FCD4'><label id='DCCCC6FCD4'><select id='DCCCC6FCD4'><dt id='DCCCC6FCD4'><span id='DCCCC6FCD4'></span></dt></select></label></b><u id='DCCCC6FCD4'></u>
          <i id='DCCCC6FCD4'><strike id='DCCCC6FCD4'><tt id='DCCCC6FCD4'><pre id='DCCCC6FCD4'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:42169
          Wire medical stent -- coverage from STAT
          Adobe

          PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical treatments and, eventually, what procedures patients undergo.

          It starts with coronary angioplasty, one of the most common procedures in medicine, performed hundreds of thousands of times a year in the U.S. alone. A balloon catheter is snaked up into a clogged artery in the heart and expanded to open the blood vessel. It leaves behind a metal scaffold, called a stent, that is used to prop the artery open.

          advertisement

          In people who have just had a heart attack, this can be lifesaving. But frequently angioplasty is used mainly to relieve chest pain, or angina. And though this use dates back decades, angioplasty and stents have never passed the basic test any new pill for relieving symptoms has to clear: outperforming a placebo in a clinical trial where patients were blinded, meaning they don’t know whether they got the treatment or not.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          JPM 2024: Verve Therapeutics looks to mainstream genome editing
          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          JPM 2024: Nvidia claims we're in biological revolution. Are we?

          SipaviaAPImagesSANFRANCISCO—Thesmallhotelmeetingroomwaspackedlikearushhoursubway.Bankersindarksuitsw